These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 36906183)
21. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Cheville JC; Reznicek MJ; Bostwick DG Am J Clin Pathol; 1997 Dec; 108(6):633-40. PubMed ID: 9384444 [TBL] [Abstract][Full Text] [Related]
22. Corpora amylacea in adenocarcinoma of the prostate: incidence and histology within needle core biopsies. Christian JD; Lamm TC; Morrow JF; Bostwick DG Mod Pathol; 2005 Jan; 18(1):36-9. PubMed ID: 15309020 [TBL] [Abstract][Full Text] [Related]
23. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354 [TBL] [Abstract][Full Text] [Related]
24. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL. Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Cheng L; Cheville JC; Bostwick DG Am J Surg Pathol; 1999 Oct; 23(10):1173-83. PubMed ID: 10524518 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Epstein JI Hum Pathol; 1995 Feb; 26(2):223-9. PubMed ID: 7860053 [TBL] [Abstract][Full Text] [Related]
27. Expression of CDX2 in benign tissue and adenocarcinoma of the prostate. Herawi M; De Marzo AM; Kristiansen G; Epstein JI Hum Pathol; 2007 Jan; 38(1):72-8. PubMed ID: 16949907 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features. Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340 [TBL] [Abstract][Full Text] [Related]
30. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Zeng L; Rowland RG; Lele SM; Kyprianou N Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584 [TBL] [Abstract][Full Text] [Related]
31. Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma. Kallakury BV; Figge J; Ross JS; Fisher HA; Figge HL; Jennings TA Hum Pathol; 1994 Jan; 25(1):92-7. PubMed ID: 7508886 [TBL] [Abstract][Full Text] [Related]
32. Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens. Svatek RS; Karam JA; Rogers TE; Shulman MJ; Margulis V; Benaim EA Prostate Cancer Prostatic Dis; 2007; 10(3):279-82. PubMed ID: 17325718 [TBL] [Abstract][Full Text] [Related]
33. Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study. Hampel OZ; Kattan MW; Yang G; Haidacher SJ; Saleh GY; Thompson TC; Wheeler TM; Marcelli M J Urol; 1998 Jun; 159(6):2220-5. PubMed ID: 9598573 [TBL] [Abstract][Full Text] [Related]
34. Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial. Bullock MJ; Srigley JR; Klotz LH; Goldenberg SL Am J Surg Pathol; 2002 Nov; 26(11):1400-13. PubMed ID: 12409716 [TBL] [Abstract][Full Text] [Related]
35. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies. Shah RB; Magi-Galluzzi C; Han B; Zhou M Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345 [TBL] [Abstract][Full Text] [Related]
37. Crystalloids in metastatic prostatic adenocarcinoma. Molberg KH; Mikhail A; Vuitch F Am J Clin Pathol; 1994 Mar; 101(3):266-8. PubMed ID: 8135180 [TBL] [Abstract][Full Text] [Related]
38. Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Sfanos KS; Wilson BA; De Marzo AM; Isaacs WB Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3443-8. PubMed ID: 19202053 [TBL] [Abstract][Full Text] [Related]
39. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. Varma M; Lee MW; Tamboli P; Zarbo RJ; Jimenez RE; Salles PG; Amin MB Arch Pathol Lab Med; 2002 May; 126(5):554-61. PubMed ID: 11958660 [TBL] [Abstract][Full Text] [Related]
40. Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma. Park HK; Kim H; Kim HG; Cho YM; Jung WY; Han HS; Hwang TS; Kwon GY; Lim SD J Korean Med Sci; 2015 May; 30(5):533-41. PubMed ID: 25931782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]